A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Virtual Tribunal Monastery
Assistance Publique - Hôpitaux de Paris
Washington University School of Medicine
Duke University
Centre Hospitalier Universitaire de Liege
New York Medical College
Duke University
Roswell Park Cancer Institute